UTHR:NASDAQ
United Therapeutics Corp
$501.98
arrow_upward
+2.95%(+14.37) 1D
Sep 8, 1:15:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$494.74
High
$502.82
Low
$479.71
Mkt. cap
21.53B
Avg. vol.
535.14K
Volume
323.74K
P/E ratio
17.95
52-wk high
$609.35
52-wk low
$392.17
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
Open
$494.74
High
$502.82
Low
$479.71
Mkt. cap
21.53B
Avg. vol.
535.14K
Volume
323.74K
P/E ratio
17.95
52-wk high
$609.35
52-wk low
$392.17
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Investing.com
·
1 hour ago
United Therapeutics at Wells Fargo conference: pipeline points to growth
www.marketscreener.com
·
6 hours ago
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com